Rachel Wenner Ruzanic in Saint Cloud, Minnesota

Home Minnesota Saint Cloud

Rachel Wenner Ruzanic has Dermatology as her primary medical specialty. Their primary office is: 1200 6th N Ave in Saint Cloud, Minnesota. There are 3 additional office locations for Rachel Wenner Ruzanic that can be viewed towards the end of their profile.

They're a part of the: Centracare Clinic medical group which has around 616 members. You can call their office at 320-252-5131 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Minnesota Medical School and graduated in 2004 (around 20 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Rachel Wenner Ruzanic Office Phone and Directions

Rachel Wenner Ruzanic
Centracare Clinic
1200 6th N Ave
Saint Cloud, Minnesota 56303
320-252-5131

Patient Ratings
Please rate your experience with Rachel Wenner Ruzanic below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 320-252-5131

Enter a starting address:

Healthcare Info for Rachel Wenner Ruzanic

Medical School: University Of Minnesota Medical School
Graduation Year: 2004
The Primary Medical Specialty for Rachel Wenner Ruzanic is listed as: Dermatology
Approximate Years of Experience: 20
PAC (PECOS ID)#: 3274671045
NPI #: 1073708608
NPI Created On: 09/06/2007
NPI Last Updated Listed as: 06/10/2009
Primary Taxonomy Code: 207N00000X
License Number:
NO LICENSE
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Medica Health Plans of Wisconsin
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals
Injection of up to 7 skin growths
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals
Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of up to 14 skin growths
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)
Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals
New patient office or other outpatient visit, typically 20 minutes
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Injection, triamcinolone acetonide, not otherwise specified, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).